Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Raptia D 30mg/20mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Ajanta Pharma Ltd

Salt Composition

Domperidone (30mg) + Rabeprazole (20mg)

Overview Raptia D 30mg/20mg Capsule SR

Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with the dual-action formulation Raptia D 30mg/20mg SR capsules. This medication alleviates common GERD symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion. Raptia D 30mg/20mg SR capsules should be taken on an empty stomach, following your doctor's prescribed dosage and regimen. Treatment duration depends on individual response and overall condition. Premature discontinuation may lead to symptom recurrence and disease exacerbation. Comprehensive disclosure of all other medications to your healthcare provider is crucial, as interactions are possible. Common, usually transient, side effects include diarrhea, abdominal discomfort, dry mouth, headache, gas, and fatigue. Report any concerning side effects promptly. Due to potential drowsiness and dizziness, refrain from driving or activities demanding concentration until the medication's effects are known. Alcohol consumption should be avoided due to increased sleepiness. Lifestyle adjustments, such as consuming cold milk and limiting hot beverages, spicy foods, and chocolate, can enhance treatment efficacy. Prior to initiating therapy, inform your physician about existing kidney or liver conditions, pregnancy, pregnancy planning, or breastfeeding.

Uses of Raptia D 30mg/20mg Capsule SR

Managing gastroesophageal reflux and peptic ulcers.

Major Benefits of Raptia D 30mg/20mg Capsule SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the 30mg/20mg Raptia D SR Capsule whole; avoid chewing, crushing, or fracturing. Consume on an empty stomach.

Common Side effects of Raptia D 30mg/20mg Capsule SR:

  • Cough
  • Headache
  • Diarrhea
  • Dizziness
  • Inflammation of the nose
  • Abdominal pain
  • Vomiting
  • Weakness
  • Nasal congestion (stuffy nose)
  • Insomnia (difficulty in sleeping)
  • Fundic gland polyps
  • Nausea
  • Constipation
  • Flatulence
  • Back pain
  • Pharyngitis

How to use Raptia D 30mg/20mg Capsule SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Consume Raptia D 30mg/20mg SR capsules on an empty stomach.

How Raptia D 30mg/20mg Capsule SR works:

Raptia D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating smoother food passage through the stomach. Rabeprazole, a proton pump inhibitor (PPI), diminishes gastric acid production, providing relief from acid indigestion and heartburn.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Raptia D 30mg/20mg SR capsules with alcohol. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Raptia D 30mg/20mg sustained-release capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Raptia D 30mg/20mg capsule is likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking Raptia D 30mg/20mg sustained-release capsules might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Raptia D 30mg/20mg sustained-release capsules cautiously. Dosage modification of Raptia D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Raptia D 30mg/20mg SR capsules cautiously, potentially requiring dose modification. Consult a physician. Raptia D 30mg/20mg SR capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.

What if you forget to take Raptia D 30mg/20mg Capsule SR :

Should you forget to take a Raptia D 30mg/20mg sustained-release capsule, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Raptia D 30mg/20mg Capsule SR

LabelValue
Addictive None.
Medication Classification Gastrointestinal system

FAQs on Raptia D 30mg/20mg Capsule SR

Raptia D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This dual-action formulation manages heartburn, acid reflux (GERD—a condition causing stomach acid to back up into the esophagus), and gastric and duodenal ulcers. Domperidone's action on gut motility facilitates easier food passage through the stomach, thus mitigating vomiting.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any inactive component of Raptia D 30mg/20mg SR Capsules should avoid its use. Individuals with pre-existing hepatic or renal impairment require careful monitoring when considering this medication.
Indeed, taking Raptia D 30mg/20mg SR capsules can lead to xerostomia (dry mouth), a side effect attributed to the Domperidone component. To alleviate this, increase your fluid intake. Keeping water readily available, especially overnight, is recommended. Reducing alcohol consumption and abstaining from smoking are also advisable. For dry mouth sufferers, alcohol-free mouthwash is preferable to minimize the potential for dental caries.
Diarrhea is a potential side effect of Raptia D 30mg/20mg sustained-release capsules. If diarrhea occurs, increase fluid intake. Dietary adjustments should include avoiding high-fat or fried foods. Consult your physician if diarrhea continues or if dehydration symptoms, such as reduced urination and dark, strong-smelling urine, appear.
Retain this medication within its original, securely sealed container or packaging. Store as directed on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Raptia D 30mg/20mg sustained-release capsules are generally well-tolerated. Nevertheless, some individuals may experience common adverse effects such as diarrhea, abdominal discomfort, gas, dry mouth, vertigo, and cephalalgia, along with less frequent or infrequent reactions. Report any ongoing issues to your physician during treatment.
For optimal absorption, Raptia D 30mg/20mg SR capsules should be administered prior to the first meal or while fasting.
Taking Raptia D 30mg/20mg sustained-release capsules may raise the likelihood of an abnormal heart rhythm (a serious arrhythmia). While this is a significant potential adverse effect, the probability of occurrence is quite small. However, the risk might be marginally elevated for individuals over sixty.
Raptia D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This dual-action formulation addresses heartburn, acid reflux (GERD), and ulcers affecting the stomach and duodenum. The medication alleviates GERD symptoms by preventing stomach acid from rising into the esophagus. Domperidone's antiemetic effect stems from its ability to enhance gut motility, facilitating efficient gastric emptying.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any excipient within Raptia D 30mg/20mg SR capsules should avoid its use. Individuals with pre-existing hepatic or renal impairment require careful monitoring when considering this medication.
Indeed, Raptia D 30mg/20mg SR capsules may induce xerostomia (dry mouth), a side effect attributed to the Domperidone component. To alleviate this, increase your fluid intake. Keep water readily available, particularly overnight. Reduce alcohol consumption and refrain from smoking. Should dry mouth persist, utilize alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a potential side effect of Raptia D 30mg/20mg SR Capsules. If diarrhea occurs, increased fluid intake is recommended. A low-fat diet is also advisable while taking this medication. Consult your physician if diarrhea continues or if you exhibit dehydration symptoms such as reduced, dark, and strong-smelling urine.
Raptia D 30mg/20mg sustained-release capsules are generally well-tolerated. Nonetheless, some individuals may experience typical side effects such as abdominal pain, diarrhea, flatulence, dry mouth, dizziness, or headache. Less frequent or infrequent adverse reactions are also possible. Report any ongoing issues to your physician during treatment.
Optimal administration of Raptiva D 30mg/20mg sustained-release capsules is before the initial daily meal or while fasting.
Taking Raptia D 30mg/20mg sustained-release capsules may raise the possibility of an irregular heartbeat, a serious but uncommon side effect. This risk might be marginally greater for individuals over 60.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Raptia D 30mg/20mg Capsul...
98
MRP 120
18% off